🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Kyowa Kirin and Knight Therapeutics Enter Into Exclusive Distribution Agreement for POTELIGEO® (mogamulizumab) for Cutaneous T-Cell Lymphoma (CTCL) Patients Across Latin America - businesswire.com

Global - South America Archived • September 29, 2026 •
Kyowa Kirin and Knight Therapeutics Enter Into Exclusive Distribution Agreement for POTELIGEO® (mogamulizumab) for Cutaneous T-Cell Lymphoma (CTCL) Patients Across Latin America  businesswire.com
Source: Latin America — Google News | https://news.google.com/rss/headlines/section/geo/Latin%20America?hl=en-US&gl=US&ceid=US:en - Read Original
"We build AI or anything ICST"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Output is a realization of Input."
"Get your business promoted today."